AI-Powered Early Detection System

Revolutionizing Gastrointestinal Cancer Diagnostics with AI

Apex AI has developed a cutting-edge AI-driven early detection system for stomach and colorectal cancer, leveraging over 1 million endoscopic imaging datasets to assist in the diagnosis of precancerous lesions, early-stage cancer, and advanced cancer.

How Apex AI’s Solution Works

• Divides the gastrointestinal tract into 14 anatomical regions for precise localization of abnormalities.

• Detects key gastrointestinal conditions, including:

  • Precancerous lesions: Atrophic gastritis, intestinal metaplasia.

  • Inflammatory conditions: Gastric ulcers, erosions, colitis.

  • Early and advanced cancers: Stomach and colorectal cancer.

• Seamlessly integrates with hospital imaging and endoscopic systems to enhance real-time clinical decision-making.

---

AI-Powered Cancer Risk Prediction & Diagnosis

Apex AI's system offers real-time image analysis, automated abnormality detection, and longitudinal disease tracking.

Core Features of AI-Assisted Endoscopic Diagnosis

• Patient Search & Data Integration

  • Connects with electronic medical records (EMR) for streamlined patient data access.

  • Allows historical comparisons of previous scans for tracking disease progression.

• Automated Endoscopic Image Interpretation

  • AI continuously analyzes real-time endoscopic footage, marking potential abnormalities.

  • Provides a comparative review of previous images to detect disease progression over time.

• Time-Based & Region-Based Disease Tracking

  • Allows doctors to monitor lesion evolution in specific locations within the gastrointestinal tract.

  • Enhances precision in monitoring high-risk patients over multiple screenings.

• High-Resolution Image Processing & Zoom Analysis

  • Enables doctors to zoom into detected lesions for a more detailed pathological assessment.

  • Reduces false positives by refining image interpretation.

---

Clinical Validation: AI vs. Human Accuracy

A retrospective clinical study comparing AI-assisted diagnosis with a panel of experienced doctors demonstrated superior accuracy in all key performance metrics.

Cancer Risk Prediction	Accuracy	Sensitivity (Recall)	Specificity	Precision	F1 Score
AI (Stomach Cancer)	95%	94%	99%	95%	0.94
AI (Colorectal Cancer)	99%	98%	99%	98%	0.98
Doctor Panel (4 Physicians Average)	67%	69%	55%	70%	0.67

Key Takeaways

• AI outperformed human doctors in accuracy, sensitivity, specificity, and precision.

• The AI model significantly reduces false negatives, ensuring high-risk lesions are detected early.

• AI-powered endoscopic analysis can improve diagnostic reliability and reduce misdiagnosis rates, leading to better patient outcomes.

---

Why AI is Critical for Early Detection in Gastrointestinal Cancer

• Early-stage stomach and colorectal cancers are often misdiagnosed or missed entirely due to subtle visual characteristics.

• AI enhances diagnostic confidence by improving detection accuracy, reducing human error, and supporting physicians in real-time.

• By adopting AI-assisted endoscopy, hospitals and clinics can drastically improve cancer survival rates worldwide.

Apex AI is at the forefront of this transformation, providing a next-generation AI diagnostic platform that will shape the future of gastrointestinal cancer detection.